hotspot -WSS

hotspot

author：entertainment 2025-09-02 17:42:40 - browse：12678

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

explore

WSS

First Opinion on colorectal cancer screening: letter and response

Blinken talks high

Study: Black kids more likely to die after surgery than white kids

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Medicare Advantage 2025 payments will dip, Biden administration says

Four alarming medical procedures we’re glad history forgot

Wikipedia

hotspot

knowledge

Supreme Court strikes down use of affirmative action

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Cancer drug shortages should be causing more outrage

Britney Spears to release memoir, 'The Woman In Me,' later this year

Malaria cases in Florida and Texas: Here’s what you need to know

Cuban government calls US nuclear submarine stop a 'provocative escalation'

In Memoriam: Notable people who died in 2023

Bird flu reported in person exposed to presumably infected cattle

United colonoscopy coverage change 'may cost lives,' doctors say

Pancreatic cancer is often deadly, but new discoveries are raising hope

entertainment

Covid silver lining: Unprecedented look at human immune system

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Hundreds died while taking an arthritis drug, but nobody alerted patients

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Vermont grapples with historic flooding as more rainstorms head for Northeast

focus

explore

knowledge

focus